Company Filing History:
Years Active: 2021-2024
Title: Karl Magnus Nilsson: Innovator in Pharmaceutical Chemistry
Introduction
Karl Magnus Nilsson is a notable inventor based in Mölndal, Sweden. He has made significant contributions to the field of pharmaceutical chemistry, particularly in the development of selective inhibitors. With a total of 2 patents, his work has implications for various therapeutic applications.
Latest Patents
Nilsson's latest patents focus on JAK1 selective inhibitors. These patents disclose compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein R-R have specific meanings defined within the documentation. Additionally, the patents include pharmaceutical compositions comprising these compounds and methods for their use.
Career Highlights
Throughout his career, Karl Magnus Nilsson has worked with prominent companies in the pharmaceutical industry, including AstraZeneca AB. His experience in these organizations has allowed him to contribute to innovative research and development projects.
Collaborations
Some of his notable coworkers include Anna Ingrid Kristina Berggren and Johan R Johansson. Their collaborative efforts have likely enhanced the research outcomes in which Nilsson has been involved.
Conclusion
Karl Magnus Nilsson's contributions to pharmaceutical chemistry through his patents and collaborations highlight his role as an influential inventor in the industry. His work continues to pave the way for advancements in therapeutic solutions.